The abstract is read at the publisher; the summary is JClub's.
In Spanish adult invasive pneumococcal disease from 2009–June 2026, serotypes shared by PCV20 and PCV21—especially 3 and 8—remained most prevalent, while unique-PCV20 and unique-PCV21 trends diverged.
- Why it matters: Adult IPD serotype patterns can shift with vaccination and COVID-19 disruptions, leaving uncertainty about which PCV20/PCV21 serotypes drive disease and how preventable fractions change over time.
- What they did: All national IPD clinical isolates were characterized from January 2009 to June 2026, tracking unique-PCV20, unique-PCV21, shared, and non-vaccine serotypes by age group and period.
- The result: Unique-PCV20 serotypes declined pre-pandemic but increased after COVID-19 due to rising serotypes 4 and 14; preventable fractions shifted from 5% (PCV21) in 2022/2023 to 15% (PCV20) in 2026 for ages 18–64, and from 20% (PCV21) in 2022 to 8% (PCV20) in 2026 for ages ≥65.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.